Ind-Ra upgrades Jubilant Ingrevia's rating to â€˜Ind AA+'; limit enhanced
India Infoline News Service |
16 Sep, 2022 |
Jubilant Ingrevia Limited informed that India Ratings and Research Private Limited has, by its rating letter dated September 14, 2022, upgraded the companyâ€™s Long-Term Issuer Rating to â€˜IND AA+â€™ from â€˜IND AAâ€™. The Outlook is Stable.
Ind-Ra has reviewed fund-based limits worth Rs550 crore, which has been enhanced from Rs440 crore.
Companyâ€™s non-fund-based facilities reviewed are worth Rs1,135 crore.
Ind-Ra maintains a consolidated perspective of JVL and its wholly-owned subsidiaries: Jubilant Infrastructure Limited ('IND A-'/Stable), Jubilant Lifesciences International Pte. Ltd, Jubilant Lifesciences NV, Jubilant Lifesciences USA Inc., and Jubilant Lifesciences International Pte. Ltd., and others.
The improvement reflects consistent operating performance and deleveraging, which will result in improved credit metrics in FY22. Given its strong market position in its major products internationally, Ind-Ra has recognised JVL's capacity to successfully pass on rising input and energy prices, despite a lag.
At around 11.38 AM, Jubilant Ingrevia was trading at Rs504, up by 0.64% against previous close of Rs500.80 on NSE. The scrip touched intraday high and low of Rs517.10 and Rs492.10 respectively, so far.
For feedback and suggestions, write to us at firstname.lastname@example.org